RIGL – rigel pharmaceuticals, inc. (US:NASDAQ)

News

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its price target raised by analysts at Piper Sandler from $15.00 to $23.00. They now have a "neutral" rating on the stock.
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its price target raised by analysts at Citigroup Inc. from $40.00 to $49.00. They now have a "buy" rating on the stock.
Rigel to Present at the Jefferies London Healthcare Conference
Rigel Pharmaceuticals Inc (RIGL) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ... [Yahoo! Finance]
Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com